{'fraction_non_alphanumeric': 0.013302034428794992, 'fraction_numerical': 0.0, 'mean_word_length': 5.004694835680751, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A Therapeutic Scheme For Oligospermia Based On Serum Levels Of FSH And Estradiol

Oligospermia is a major cause of infertility in couples. It is usually managed by assisted reproductive techniques. In these techniques the female partners are treated, while the male partners having this medical problem are left untreated! Though several empirical therapies are available to treat oligospermia, it is difficult to identify a therapy that is most likely to benefit a man having oligospermia. This leads to trial of different therapies resulting in varied success rates. These empirical therapies put emphasis on the stimulatory role of testosterone in the process of spermatogenesis while estrogens are considered inhibitory in this respect. In the last decade, however, positive role of estrogens in male reproduction has been reported by some authors. In view of this evidence, a therapeutic scheme for oligospermia based on serum levels of FSH and estradiol, is presented. Its aim is to develop a system by which a clinician may possibly identify a suitable therapy before starting the treatment of an infertile man. Thus it may reduce unnecessary trial of treatments and save on costs and time, and it may save some women from being treated for a problem of male infertility.